Non-pharmacologic Sleep Interventions — MCQs
A 32-year-old man comes to the physician complaining of excessive sleepiness for the past several months. He reports falling asleep while dealing with customers and had a near accident when he fell asleep while driving. The patient reports that he occasionally hears voices while falling asleep and finds himself "temporarily frozen" and unable to move upon awakening. Which of the following is the most appropriate treatment for this patient?
Which anxiolytic acts through 5-HT1A receptor partial agonism without exhibiting significant anticonvulsant or muscle relaxant properties?
Best therapy suited to teach daily life skills to a child with intellectual disability:
Bright light treatment has been found to be most effective in treatment of?
Which of the following treatments cannot be used for management of Obsessive Compulsive Disorder (OCD)?
A child presents with complaints of bed wetting. What is the first line of treatment?
All are used in the treatment of nocturnal enuresis except?
Which human leukocyte antigen (HLA) complex is associated with narcolepsy?
A 49-year-old man presents with a 10-year history of increasing knee and hip pain, exacerbated by end-of-day activity. Over the past year, he has developed increasing drowsiness at work and his wife reports he is a severe snorer. For the last month, he has experienced episodes of sharp, colicky, right upper abdominal pain. His physical examination reveals a temperature of 37°C, pulse of 82/min, respirations of 10/min, and blood pressure of 140/85 mm Hg. He is 175 cm tall and weighs 156 kg (BMI 51). Laboratory findings include glucose of 139 mg/dL, HbA1c of 10%, total cholesterol of 229 mg/dL, and HDL cholesterol of 33 mg/dL. Arterial blood gas measurements show pH 7.35, PCO2 50 mm Hg, and PO2 75 mm Hg. Which of the following additional conditions is most likely present in this man?
Sleep apnoea is defined as a temporary pause in breathing during sleep lasting at least:
Non-pharmacologic Sleep Interventions Indian Medical PG Practice Questions and MCQs
Question 1: A 32-year-old man comes to the physician complaining of excessive sleepiness for the past several months. He reports falling asleep while dealing with customers and had a near accident when he fell asleep while driving. The patient reports that he occasionally hears voices while falling asleep and finds himself "temporarily frozen" and unable to move upon awakening. Which of the following is the most appropriate treatment for this patient?
- A. Melatonin
- B. Modafinil (Correct Answer)
- C. Clonazepam
- D. Continuous positive airway pressure
Explanation: ***Modafinil*** - The patient's symptoms of **excessive daytime sleepiness** (EDS), **hypnagogic hallucinations** (hearing voices while falling asleep), and **sleep paralysis** are classic signs of **narcolepsy**. - **Modafinil** is a **non-amphetamine stimulant** that promotes wakefulness and is a first-line treatment for narcolepsy, improving alertness and reducing EDS. *Melatonin* - **Melatonin** is a hormone involved in regulating the **sleep-wake cycle** and is primarily used for **insomnia**, **jet lag**, or **circadian rhythm disorders**. - It is not effective for treating the hallmark symptoms of narcolepsy, such as cataplexy or excessive daytime sleepiness. *Clonazepam* - **Clonazepam** is a **benzodiazepine** that acts as a central nervous system depressant, primarily used for **anxiety disorders**, seizures, and some sleep disorders like **REM sleep behavior disorder**. - While it can help with some parasomnias, it would worsen daytime sleepiness in a patient with narcolepsy and is not a primary treatment for its core symptoms. *Continuous positive airway pressure* - **Continuous positive airway pressure (CPAP)** is the standard treatment for **obstructive sleep apnea (OSA)**, a condition characterized by recurrent upper airway collapse during sleep. - Although OSA can cause excessive daytime sleepiness, the patient's additional symptoms of hypnagogic hallucinations and sleep paralysis are not typical of OSA, making narcolepsy and its specific treatments more appropriate.
Question 2: Which anxiolytic acts through 5-HT1A receptor partial agonism without exhibiting significant anticonvulsant or muscle relaxant properties?
- A. Diazepam
- B. Zolpidem
- C. Phenobarbitone
- D. Buspirone (Correct Answer)
Explanation: ***Buspirone*** - **Buspirone** is a unique anxiolytic that primarily acts as a **partial agonist at 5-HT1A receptors**. - Unlike benzodiazepines, it lacks significant **anticonvulsant**, **muscle relaxant**, or **sedative-hypnotic properties** and does not lead to physical dependence or withdrawal. *Diazepam* - **Diazepam** is a **benzodiazepine** that acts by enhancing the effect of **GABA** at GABA-A receptors, leading to significant anxiolytic, sedative, muscle relaxant, and anticonvulsant effects. - It does not primarily act via **5-HT1A receptor partial agonism**. *Zolpidem* - **Zolpidem** is a **non-benzodiazepine hypnotic** that selectively binds to the **GABA-A receptor** subunit, primarily mediating sedative effects. - While it's used for insomnia, it doesn't primarily act as a **5-HT1A partial agonist** and is not typically used for its anxiolytic properties in the same way as buspirone. *Phenobarbitone* - **Phenobarbitone** is a **barbiturate** that acts by prolonging the opening of **chloride channels** associated with GABA-A receptors, leading to strong sedative, hypnotic, and anticonvulsant effects. - Its mechanism of action is distinct from **5-HT1A receptor partial agonism**, and it carries a high risk of dependence and overdose.
Question 3: Best therapy suited to teach daily life skills to a child with intellectual disability:
- A. Applied Behavior Analysis (ABA) (Correct Answer)
- B. Cognitive Behavioral Therapy (CBT)
- C. Social skills training
- D. Self-instructional training
Explanation: **Applied Behavior Analysis (ABA)** - **ABA** is a highly structured, evidence-based therapy that focuses on teaching specific skills by breaking them down into smaller steps and using **positive reinforcement**. - It is particularly effective for children with intellectual disabilities in acquiring **adaptive daily living skills**, communication, and social behaviors. *Cognitive Behavioral Therapy (CBT)* - **CBT** primarily targets changing negative thought patterns and behaviors, requiring a level of abstract reasoning that may be challenging for children with significant intellectual disabilities. - While it can be adapted, its core methods rely on cognitive processes that might not be the most direct approach for teaching basic daily life skills to a mentally challenged child. *Social skills training* - **Social skills training** focuses specifically on improving social interactions and communication within social contexts. - While important for overall development, it is a subcomponent of broader skill development and may not directly address all aspects of **daily living skills** in a comprehensive manner. *Self-instructional training* - **Self-instructional training** involves teaching individuals to guide themselves through tasks using internal speech or self-talk, which relies on a child's ability to internalize and follow complex verbal instructions. - This approach might be too cognitively demanding for a child with significant developmental delays when the primary goal is mastering basic, functional daily life skills.
Question 4: Bright light treatment has been found to be most effective in treatment of?
- A. Schizophrenia
- B. Anorexia Nervosa
- C. Obsessive compulsive disorder
- D. Seasonal Affective Disorder (Correct Answer)
Explanation: ***Seasonal Affective Disorder*** - **Bright light therapy** is a primary and highly effective treatment for **Seasonal Affective Disorder (SAD)**, which is characterized by depressive symptoms occurring during specific seasons, typically winter. - Exposure to bright light helps regulate the body's **circadian rhythm** and neurotransmitter function, particularly **melatonin** and **serotonin**, which are often disrupted in SAD. *Schizophrenia* - **Bright light treatment** is not a primary or established treatment for **schizophrenia**, a severely debilitating psychiatric disorder primarily managed with antipsychotic medications. - While some studies explore its potential as an adjunct for sleep disturbances in schizophrenia, it does not address the core psychotic symptoms. *Anorexia Nervosa* - **Bright light treatment** is not a generally recognized or effective treatment for **anorexia nervosa**, an eating disorder characterized by extreme restrictive eating, low body weight, and distorted body image. - Treatment for anorexia nervosa typically involves psychotherapy, nutritional rehabilitation, and medical management of complications. *Obsessive compulsive disorder* - **Bright light treatment** is not indicated as a primary treatment for **obsessive-compulsive disorder (OCD)**, which is effectively managed with cognitive-behavioral therapy (CBT), particularly exposure and response prevention (ERP), and selective serotonin reuptake inhibitors (SSRIs). - While sleep disturbances can co-occur with OCD, light therapy does not target the core obsessive thoughts and compulsive behaviors.
Question 5: Which of the following treatments cannot be used for management of Obsessive Compulsive Disorder (OCD)?
- A. Fluoxetine
- B. Carbamazepine (Correct Answer)
- C. Cognitive Behaviour Therapy
- D. Clomipramine
Explanation: ***Carbamazepine*** - **Carbamazepine** is an **anticonvulsant** and **mood stabilizer** primarily used for epilepsy and bipolar disorder. - It does not have established efficacy for the treatment of **Obsessive-Compulsive Disorder (OCD)**. *Fluoxetine* - **Fluoxetine** is a **Selective Serotonin Reuptake Inhibitor (SSRI)** and is a **first-line pharmacotherapy** for OCD. - SSRIs, including fluoxetine, are effective in reducing the severity of **obsessions and compulsions**. *Cognitive Behaviour Therapy* - **Cognitive Behavioural Therapy (CBT)**, specifically **Exposure and Response Prevention (ERP)**, is the **gold standard psychotherapy** for OCD. - It involves gradually exposing patients to feared situations or thoughts while preventing their ritualistic responses. *Clomipramine* - **Clomipramine** is a **tricyclic antidepressant (TCA)** that has potent inhibitory effects on **serotonin reuptake**. - It is one of the **most effective medications** for OCD, often used when SSRIs are insufficient.
Question 6: A child presents with complaints of bed wetting. What is the first line of treatment?
- A. Bed alarm technique (Correct Answer)
- B. Motivational therapy
- C. Oxybutynin
- D. Desmopressin
Explanation: ***Bed alarm technique*** - The **bed alarm technique** is considered the most effective first-line treatment for **nocturnal enuresis** in children. - It works through **classical conditioning**, training the child to wake up in response to bladder fullness. *Motivational therapy* - **Motivational therapy** can be a useful adjunct to other treatments, but it is not typically the sole **first-line therapy** due to varying effectiveness. - It focuses on building the child's confidence and encouraging dryness but does not directly address the physiological aspects of bedwetting. *Oxybutynin* - **Oxybutynin** is an anticholinergic medication that can reduce bladder contractions and increase bladder capacity. - It is usually reserved for cases where **bedwetting alarms** and **desmopressin** have been ineffective, or when there is an identifiable **overactive bladder component**. *Desmopressin* - **Desmopressin** is an antidiuretic hormone analogue that reduces urine production during the night. - While effective, it is often considered a **second-line treatment** after behavioral interventions like the bed alarm, or when rapid but temporary improvement is desired.
Question 7: All are used in the treatment of nocturnal enuresis except?
- A. Voiding of urine before sleeping (Correct Answer)
- B. Imipramine
- C. Alarm setup
- D. Maintenance of calendar of day night wetting
Explanation: ***Voiding of urine before sleeping*** - **Voiding before sleep** is a **general hygiene measure and preventive advice** rather than a specific therapeutic intervention for nocturnal enuresis. - While it may reduce bladder volume at bedtime, it does **not address the underlying pathophysiology** of nocturnal enuresis (arousal deficit, nocturnal polyuria, or detrusor overactivity). - It is **routine advice** given to all children, not a targeted treatment modality for curing enuresis. *Imipramine* - **Imipramine**, a tricyclic antidepressant, is an established **pharmacological treatment** for nocturnal enuresis. - Its mechanisms include: **anticholinergic effects** (increasing bladder capacity and functional bladder capacity), **alpha-adrenergic effects** (increasing bladder outlet resistance), and **antidiuretic effects**. - Typical dosing: **25-50 mg at bedtime**, with success rates of 40-60%. *Alarm setup* - **Bed-wetting alarms** are the **first-line behavioral therapy** with the highest long-term cure rates (60-70% success). - Works through **classical conditioning**: the alarm triggers when moisture is detected, training the child to either wake to void or develop nocturnal bladder control. - Requires **8-12 weeks** of consistent use and has the lowest relapse rates among treatments. *Maintenance of calendar of day night wetting* - **Voiding diary/calendar** is an essential **behavioral intervention** for monitoring and managing nocturnal enuresis. - Helps identify patterns, track treatment progress, and provides **positive reinforcement** through visual feedback. - Part of comprehensive behavioral management alongside fluid restriction and scheduled voiding during daytime.
Question 8: Which human leukocyte antigen (HLA) complex is associated with narcolepsy?
- A. DR2 (Correct Answer)
- B. DR3
- C. DR4
- D. B4
Explanation: Narcolepsy, particularly Type 1 (narcolepsy with cataplexy), has one of the strongest known genetic associations in medicine [1]. The correct answer is **HLA-DR2**, specifically the subtype **HLA-DRB1*1501** and its closely linked allele **HLA-DQB1*0602**. 1. **Why HLA-DR2 is correct:** Over 95% of patients with narcolepsy and cataplexy carry the HLA-DR2/DQB1*0602 complex. This association supports the autoimmune theory of the disease, where the immune system selectively destroys **hypocretin (orexin)-producing neurons** in the lateral hypothalamus. Hypocretin is essential for maintaining wakefulness and regulating REM sleep. 2. **Why other options are incorrect:** * **HLA-DR3:** Associated with autoimmune conditions like Type 1 Diabetes Mellitus, SLE, and Graves' disease. * **HLA-DR4:** Classically associated with Rheumatoid Arthritis and Type 1 Diabetes Mellitus. * **HLA-B27 (related to B4):** HLA-B alleles (like B27) are typically associated with seronegative spondyloarthropathies (e.g., Ankylosing Spondylitis), not sleep disorders. **Clinical Pearls for NEET-PG:** * **The Pentad of Narcolepsy:** Excessive daytime sleepiness (earliest symptom), Cataplexy (most specific), Hypnagogic hallucinations, Sleep paralysis, and Fragmented nocturnal sleep. * **Diagnosis:** Gold standard is the **Multiple Sleep Latency Test (MSLT)** showing a mean sleep latency <8 minutes and ≥2 Sleep Onset REM Periods (SOREMPs). * **CSF Findings:** Low or absent **Hypocretin-1 (Orexin-A)** levels in the cerebrospinal fluid are diagnostic for Type 1 Narcolepsy [1]. * **Treatment:** Modafinil is the first-line for daytime sleepiness; Sodium Oxybate is the drug of choice for cataplexy.
Question 9: A 49-year-old man presents with a 10-year history of increasing knee and hip pain, exacerbated by end-of-day activity. Over the past year, he has developed increasing drowsiness at work and his wife reports he is a severe snorer. For the last month, he has experienced episodes of sharp, colicky, right upper abdominal pain. His physical examination reveals a temperature of 37°C, pulse of 82/min, respirations of 10/min, and blood pressure of 140/85 mm Hg. He is 175 cm tall and weighs 156 kg (BMI 51). Laboratory findings include glucose of 139 mg/dL, HbA1c of 10%, total cholesterol of 229 mg/dL, and HDL cholesterol of 33 mg/dL. Arterial blood gas measurements show pH 7.35, PCO2 50 mm Hg, and PO2 75 mm Hg. Which of the following additional conditions is most likely present in this man?
- A. Hashimoto thyroiditis
- B. Hypertrophic cardiomyopathy
- C. Laryngeal papillomatosis
- D. Nonalcoholic fatty liver disease (Correct Answer)
Explanation: ### Explanation **Correct Answer: D. Nonalcoholic fatty liver disease (NAFLD)** **1. Why it is correct:** The patient presents with a classic constellation of **Metabolic Syndrome** and **Obesity Hypoventilation Syndrome (OHS)**. Key findings include morbid obesity (BMI 51), Type 2 Diabetes (HbA1c 10%), dyslipidemia, and daytime hypercapnia ($PCO_2$ 50 mm Hg) [1]. * **NAFLD** is the hepatic manifestation of metabolic syndrome and is highly prevalent in patients with morbid obesity and insulin resistance [2]. * The "sharp, colicky, right upper abdominal pain" suggests **cholelithiasis** (gallstones), which is also strongly associated with obesity and rapid weight fluctuations. * The combination of snoring, daytime somnolence, and hypercapnia in an obese patient confirms OHS (Pickwickian Syndrome), which frequently coexists with NAFLD. **2. Why the other options are incorrect:** * **A. Hashimoto thyroiditis:** While hypothyroidism can cause weight gain, it does not explain the colicky RUQ pain or the specific metabolic profile (diabetes/dyslipidemia) as directly as NAFLD does in this context. * **B. Hypertrophic cardiomyopathy:** This is a genetic structural heart disease. While this patient may develop *congestive* heart failure or *Cor Pulmonale* due to chronic hypoxia, HCM is not etiologically linked to obesity or metabolic syndrome. * **C. Laryngeal papillomatosis:** This is caused by HPV 6 and 11. While it can cause airway obstruction, it is unrelated to the patient's metabolic markers, BMI, or abdominal symptoms. **3. NEET-PG High-Yield Pearls:** * **Obesity Hypoventilation Syndrome (OHS):** Defined as the triad of Obesity (BMI >30), daytime hypercapnia ($PaCO_2 >45$ mmHg), and sleep-disordered breathing, in the absence of other causes of hypercapnia [1]. * **NAFLD Spectrum:** Ranges from simple steatosis to Non-alcoholic Steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma [3]. It is now the most common cause of chronic liver disease worldwide. * **Metabolic Syndrome Criteria (ATP III):** Abdominal obesity, High TG, Low HDL, Hypertension, and High Fasting Glucose. This patient meets almost all criteria.
Question 10: Sleep apnoea is defined as a temporary pause in breathing during sleep lasting at least:
- A. 40 seconds
- B. 30 seconds
- C. 20 seconds
- D. 10 seconds (Correct Answer)
Explanation: **Explanation:** **Correct Answer: D. 10 seconds** **Understanding the Concept:** In clinical sleep medicine, **Apnoea** is defined as the total or near-total cessation of airflow (at least a 90% reduction) for a duration of **at least 10 seconds**. This threshold is used because pauses shorter than 10 seconds are generally considered physiological and do not typically lead to significant oxygen desaturation or sleep fragmentation [1]. Sleep apnoea is further categorized into: 1. **Obstructive (OSA):** Continued respiratory effort against a collapsed airway (most common) [1]. 2. **Central (CSA):** Lack of respiratory effort due to a failure of the brain's drive to breathe [1]. 3. **Mixed:** A combination of both. **Analysis of Incorrect Options:** * **A, B, and C (40, 30, and 20 seconds):** While an apnoeic event can certainly last this long (and often does in severe cases), these are not the *minimum* diagnostic criteria. **High-Yield Clinical Pearls for NEET-PG:** * **Hypopnoea:** Defined as a reduction in airflow (≥30%) for ≥10 seconds associated with either oxygen desaturation (≥3% or 4%) or an arousal. * **Apnoea-Hypopnoea Index (AHI):** The gold standard for grading severity [2]. It is the number of apnoeas and hypopnoeas per hour of sleep. * *Mild:* 5–15 events/hr * *Moderate:* 15–30 events/hr * *Severe:* >30 events/hr * **Gold Standard Investigation:** Overnight Polysomnography (PSG). * **Treatment of Choice (OSA):** Continuous Positive Airway Pressure (CPAP) [2]. * **Common Association:** Obesity (Pickwickian Syndrome), retrognathia, and hypothyroidism.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free